Navigation Links
QRxPharma to Sponsor Symposium at 13th World Congress on Pain Meeting
Date:8/31/2010

eted multiple comparative studies evaluating its efficacy and safety against equianalgesic doses of morphine, oxycodone and Percocet® for the treatment of acute pain.  Data collected from these studies provided additional guidance for optimizing the design and initiation of two pivotal Phase 3 studies required for New Drug Application (NDA) filings with the US Food and Drug Administration (FDA).  QRxPharma expects to complete its Phase 3 program Q4 2010 and file its NDA for MoxDuo®IR by Q1 2011.  The Company's preclinical and clinical pipeline includes other technologies in the fields of pain management, neurodegenerative disease and venomics.  For more information, visit www.qrxpharma.com.

About IASP

The International Association for the Study of Pain (IASP) is the leading professional forum for science, practice, and education in the field of pain.   The biennial World Congress on Pain meeting, is the world's largest pain-related gathering, and is international and multidisciplinary in scope.

(1)75 years of opioid research: the exciting but vain quest for the Holy Grail – Alistair D. Corbett, Graeme Henderson, Alexander T. McKnight and Stewart J. Paterson: British Journal of Pharmacology (2006) 147, S153-162.

(2)Gregorian Jr., RS et al.  J Pain (May 2010); (EPub ahead of Print): 1-14

(3)Kwong JW, et al.  Ann Pharmacotherapy (2010); 44:630-640


'/>"/>
SOURCE QRxPharma
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. QRxPharma Doses First Patients in Phase III Clinical Trial Program for its Dual Opioid Pain Therapy
2. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
3. QRxPharma Releases Additional Phase 3 Data for Q8003IR Dual Opioid Pain Therapy
4. QRxPharma Successfully Completes Comparative Study for Dual-Opioid(TM) Pain Therapy
5. QRxPharma Inks Deal with Patheon for the Manufacture of MoxDuo(TM)CR
6. QRxPharma Limited Announces A$21.6 Million Fully Underwritten Capital Raising
7. QRxPharma Initiates Second Pivotal Phase 3 Study of MoxDuo(TM)IR Dual-Opioid(TM) for NDA Submission
8. QRxPharma Limited and China Aoxing Pharmaceutical Company Announce Strategic Alliance for Development of MoxDuo(R)IV
9. QRxPharma Releases Additional Pivotal Phase 3 Combination Rule Study Data for MoxDuo(R)IR in Patients with Post-Surgical Pain
10. QRxPharma Successfully Completes Comparative Phase 1 Proof-of-Concept Study for MoxDuo(R) CR Tablet Formulation
11. QRxPharma Receives Positive Feedback from Scientific Advice Meetings in Europe on MoxDuo®IR Development and Registration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... , Aug. 31, 2015  Regulatory affairs ... government, where regulations are often strict and legislation ... driving a demand for professionals who have a ... regulations across a product lifecycle and demonstrate its ... University of California, Irvine Extension , in ...
(Date:8/31/2015)... August 31, 2015 ... OTCQX: BLGTY) ("BioLight" or the "Company"), a firm ... in ophthalmology and cancer diagnostics, today announced that ... has identified several new genetic markers with high ... patients treated with bisphosphonate drugs and was able ...
(Date:8/31/2015)... YORK , August 31, 2015 ... they have entered into an exclusive licensing agreement for ... in the estimated $300 million USD veterinary dermatology market, ... (ultramicronized palmitoylethanolamide) to support healthy skin in dogs and ... Italy , and has been received ...
Breaking Medicine Technology:UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 2UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 2BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 4Premune Broadens Portfolio With Novel Innovet Skin Health Product 2Premune Broadens Portfolio With Novel Innovet Skin Health Product 3Premune Broadens Portfolio With Novel Innovet Skin Health Product 4
... CHICAGO, June 3, 2011 Cornerstone Pharmaceuticals ... findings from a Phase I clinical trial of Cornerstone,s ... Leukemia (AML). Data will be presented at the 47th ... http://www.chicago2011.asco.org/ . Cornerstone is a leader in the ...
... June 3, 2011 DURECT Corporation (Nasdaq: DRRX ... be presenting at the Jefferies Healthcare Conference on Tuesday, June ... held at the Grand Hyatt in New York.   ... webcast of the presentation will be available by accessing DURECT,s ...
Cached Medicine Technology:Wake Forest Baptist Medical Center and Cornerstone Pharmaceuticals Present Interim Data From Phase I Trial of CPI-613 in Acute Myeloid Leukemia 2Wake Forest Baptist Medical Center and Cornerstone Pharmaceuticals Present Interim Data From Phase I Trial of CPI-613 in Acute Myeloid Leukemia 3Wake Forest Baptist Medical Center and Cornerstone Pharmaceuticals Present Interim Data From Phase I Trial of CPI-613 in Acute Myeloid Leukemia 4
(Date:9/1/2015)... Angeles, CA (PRWEB) , ... September 01, 2015 , ... ... and makes the massage robots more effective and humanlike than ever before. With the ... chairs, the Ogawa Refresh and the Ogawa Active SuperTrac. , As in its ...
(Date:9/1/2015)... ... September 01, 2015 , ... Situations requiring ... arise at the most convenient time for everyone involved. These occasions highlight the ... Universal Translation Services has real people available to handle any translation ...
(Date:9/1/2015)... CINCINNATI, OHIO (PRWEB) , ... September 01, 2015 , ... ... US today at JourneyLite of Cincinnati. In the last month the FDA has ... ReShape Duo ™. These procedures represent the first incisionless, reversible, weight loss ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... about new patients directly from Practice Perfect to FOTO enabling cost and time ... , Steven Presement, President of Practice Perfect, stated "FOTO is a ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... Anthony J. ... the Super Lawyers 2015 for his third consecutive year in a row. Through ... accomplishments of helping people. , Born in Niagara Falls, New York, Tantillo is a ...
Breaking Medicine News(10 mins):Health News:Ogawa World USA Releases New Massage Chairs to the US 2Health News:Ogawa World USA Releases New Massage Chairs to the US 3Health News:Universal Translation Services Provides Quality Translations 24 Hours a Day Including Weekends 2Health News:Universal Translation Services Provides Quality Translations 24 Hours a Day Including Weekends 3Health News:Dr. Trace Curry Performs First ORBERA™ Intra-gastric Balloon in Ohio at JourneyLite, a New Incisionless Option For The Treatment of Obesity 2Health News:FOTO Announces New Integration Partnership with Practice Perfect 2
... diet high in fiber from fruit and soy foods ... especially cough with phlegm.// ,Researchers studied more ... more than 44,000 patients without the respiratory problem. Participants ... certain foods were associated with a reduced risk of ...
... from Switzerland say they find no increase risk of ... control their asthma.// ,National asthma guidelines recommend inhaled ... with persistent forms of the disease. But doctors have ... of youngsters who take them. The fear stems from ...
... Topical ointments used to treat the symptoms of ... people do not work for more than a ... recent study.According to researchers, the current guidelines in ... of topical treatments containing non-steroidal anti-inflammatory drugs to ...
... approved drug for the treatment of alcohol dependence. But one ... orally, which can reduce medication compliance and can be absorbed ... an injection of naltrexone and the benefit of its use ... and they were randomly assigned to get an injection of ...
... may not want to opt for low-fat salad dressing ... absorb nutrients found in vegetables.// ,Researchers studied ... consumed lettuce and other vegetables topped with salad dressing ... oil. Blood tests were taken every 11 hours following ...
... Vestibular neuritis causes dizziness due to a viral infection of ... nausea could be diagnosed with vestibular neuritis. A new ... of vestibular neuritis. // ,Researchers conducted a study to ... of the two could improve the outcome of patients with ...
Cached Medicine News:
Titanium hemi arthroplasty implant for degenerative and post-traumatic arthritis of first metatarsophalangeal joint....
... Cranial Nerve Electrodes provide direct cranial ... Their patented circumferential design provides sensitive ... high-quality, stable real-time recordings. This unique ... during the removal of acoustic neuromas, ...
... of Ad-Techs products, our Sphenoidal Electrodes are manufactured ... available in stainless steel or platinum and feature ... (70 mm) long, 21 gauge (0.83 mm) introducing ... as kits or sets. You can also choose ...
... Stellate Harmonie workstation is a medical device ... high quality video capability, and archiving demands ... review functions A framework that helps organize ... of data A centralized database and powerful ...
Medicine Products: